Literature DB >> 10680816

AIDS- and non-AIDS-related PML association with distinct p53 polymorphism.

C Power1, J G Gladden, W Halliday, M R Del Bigio, A Nath, W Ni, E O Major, J Blanchard, M Mowat.   

Abstract

A population-based analysis of progressive multifocal leukoencephalopathy (PML) showed PML frequencies of 5.1% among patients with AIDS and 0.07% among patients with hematologic malignancies, but similar clinical features of PML in both groups. Sequencing of the p53 gene, exon 4, showed heterozygosity (Arg-Pro) at codon 72 in five of six PML patients. These findings indicate that frequencies of non-AIDS- and AIDS-related PML differ markedly but p53 polymorphisms may influence the occurrence of PML in both groups.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10680816     DOI： 10.1212/wnl.54.3.743

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  27 in total

1.  Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?

Authors:  Renaud A Du Pasquier; Igor J Koralnik
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

3.  Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.

Authors:  Marco A Lima; Angela Marzocchetti; Patrick Autissier; Troy Tompkins; Yiping Chen; Jennifer Gordon; David B Clifford; Rajesh T Gandhi; Nagagopal Venna; Joseph R Berger; Igor J Koralnik
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  A 41-year-old female with progressive multifocal leukoencephalopathy after liver transplant.

Authors:  Zahra Ahmadinejad; Fatemeh Talebi; Niloofar Ayoobi Yazdi; Fereshteh Ghiasvand
Journal:  J Neurovirol       Date:  2019-05-28       Impact factor: 2.643

5.  JC virus-induced Progressive Multifocal Leukoencephalopathy.

Authors:  A Sami Saribas; Ahmet Ozdemir; Cathy Lam; Mahmut Safak
Journal:  Future Virol       Date:  2010-05       Impact factor: 1.831

6.  Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Authors:  Jérôme Hadjadj; Aurélien Guffroy; Christophe Delavaud; Guillaume Taieb; Isabelle Meyts; Anne Fresard; Nathalie Streichenberger; Anne-Sophie L'Honneur; Flore Rozenberg; Maud D'Aveni; Claire Aguilar; Jérémie Rosain; Capucine Picard; Nizar Mahlaoui; Marc Lecuit; Olivier Hermine; Olivier Lortholary; Felipe Suarez
Journal:  J Clin Immunol       Date:  2018-12-14       Impact factor: 8.317

7.  Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation.

Authors:  Marco A Lima; Douglas W Hanto; Michael P Curry; Michael T Wong; Xin Dang; Igor J Koralnik
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

8.  Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.

Authors:  Pankaj Seth; Frank Diaz; Eugene O Major
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

9.  Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

Authors:  R A Du Pasquier; J E Schmitz; J Jean-Jacques; Y Zheng; J Gordon; K Khalili; N L Letvin; I J Koralnik
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

Authors:  Kenneth R Carson; Andrew M Evens; Elizabeth A Richey; Thomas M Habermann; Daniele Focosi; John F Seymour; Jacob Laubach; Susie D Bawn; Leo I Gordon; Jane N Winter; Richard R Furman; Julie M Vose; Andrew D Zelenetz; Ronac Mamtani; Dennis W Raisch; Gary W Dorshimer; Steven T Rosen; Kenji Muro; Numa R Gottardi-Littell; Robert L Talley; Oliver Sartor; David Green; Eugene O Major; Charles L Bennett
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.